Background The long-term trajectories of estimated glomerular filtration rate (eGFR) and their relation to early proteinuria ...
With an expiration date still more than a year away, here's what the latest details reveal.
These 4 big technology bets will reshape the global economy in 2026 ...
Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with primary focal segmental ...
Here's how your social life could affect your dementia risk.
Corewell Health has big plans for its Butterworth Hospital campus in Grand Rapids.
On April 17th, our Board declared a cash dividend of $0.20 per share on the company's voting common stock, expected to be ...
Not intended for the UK Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with prima ...
Korro Bio, Inc. ( KRRO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 1:30 PM EST ...
SoftwareOne, WWT, Long View, Blue Mantis, DXC, Presidio, ePlus, EPAM, Optiv, Bluum and other solution provider CEOs share ...
WD-40 Company (NASDAQ:WDFC) Q1 2026 Earnings Call Transcript January 8, 2026 WD-40 Company misses on earnings expectations.
Yeah, well, actually, the actual increase actually happens on a quarterly basis every quarter because it's being accrued throughout the previous year when we do those and then when we issue the new ...